About the Founder

Discern Genomics was founded by Dr Guan Wang in April 2025. A geneticist by training, she has over a decade of academic research experience spanning human genetics, exercise biology, and health sciences.

Dr Wang completed her PhD in Integrated Biology at the University of Glasgow in 2013, where her research explored the intersections of genomics, exercise, and health. She subsequently held academic research positions at the University of Glasgow and later the University of Brighton, where she progressed through research roles and served as a Senior Research Fellow until 2023.

During her academic career, Dr Wang contributed to interdisciplinary research across genetics, exercise, and health-related fields and has authored more than 50 peer-reviewed publications, including research articles, reviews, and book chapters. Her work has been presented at national and international scientific conferences. She is a full member of the British Society for Genetic Medicine (BSGM) and the Physiological Society. Her academic publications and research contributions can be viewed through her ORCID research profile.

Since 2018, Dr Wang has collaborated with researchers at Yale School of Medicine, with early work focusing on genetics and exercise biology. From 2021, this collaboration expanded to include research exploring complex conditions such as long-haul COVID-19 and has led to wider collaborations across Yale University.

Following her academic career, Dr Wang’s work has increasingly focused on research-informed genomic education with counselling-informed support, alongside continued collaboration with researchers and clinicians. As part of this work, she contributed to patient communities and research teams in amyotrophic lateral sclerosis (ALS) research through her role as a Research & Development Consultant at Beijing AskHelpU Medical Technology Co., Ltd. (2023–2026), contributing to the translation of emerging genetic findings and biological mechanisms into accessible insights and their relevance to research teams and patient communities.

Recognising that genetic information may raise complex personal questions and emotional responses, Dr Wang has undertaken counselling training to support a reflective, person-centred, and communication-focused approach to genomic education. She completed the Level 2 Certificate in Counselling Skills (2025) and Level 3 Certificate in Counselling Studies (2026) through the Counselling & Psychotherapy Training Academy (CPTA), awarded by the Counselling & Psychotherapy Central Awarding Body (CPCAB).

Through Discern Genomics, Dr Wang brings together scientific expertise in genomics with counselling-informed communication and support to help individuals and families better understand complex genetic information in a non-clinical educational setting.

Discern Genomics provides research-informed genomic education and supportive discussion. The service does not provide medical diagnosis, clinical genetic counselling, psychotherapy, treatment, or medical advice, and is not a substitute for regulated healthcare or clinical genetics services.

Professional Journey at a Glance

(Academic—Translational—Client-Facing)

Dr Guan Wang, founder of Discern Genomics Limited

2009–2023 | Academic Research

PhD in Integrated Biology

University of Glasgow (2009–2013)

Academic Research Positions:

Postdoctoral Researcher

University of Glasgow (2013–2014)

Research Officer — Research Fellow — Senior Research Fellow
(career progression)

University of Brighton (2014–2023)

Research Areas Included:

Human genetics and genomics;

Exercise biology;

Health sciences and translational research;

Computational genomics and bioinformatics.

International Research Collaborations:

Yale School of Medicine (2018–present);

Additional collaborations with Yale University departments and researchers arising from this work.

2021–Present | Translational & Research-Informed Work

Collaborative Research:

Research Affiliate, Yale University

Long-haul COVID-19 research with Yale collaborators (2021–present)

Advisory and Research-Support Roles:

Research & Development Consultant

Beijing AskHelpU Medical Technology Co., Ltd. (2023–2026)

Areas of Contribution Included:

Amyotrophic lateral sclerosis (ALS) and neuromuscular disease research;

Interpretation of emerging genetic and genomic evidence;

Translational and interdisciplinary research support;

Communication of scientific findings across research, clinical, and patient communities.

2025–Present | Client-Facing Genomic Support

Founder, Discern Genomics Limited
Established April 2025

Providing research-informed, non-clinical genomic education with counselling-informed communication and support for individuals and families

Professional Development Includes:

CPCAB Level 2 Certificate in Counselling Skills (2025);

CPCAB Level 3 Certificate in Counselling Studies (2026);

Ongoing professional development in genomics, communication, and counselling-informed practice.